Inogen, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)

9 Months Ended

Sep. 30, 2020

The activity for stock options under the Company’s stock plans for the nine months ended September 30, 2020 is as follows:

							Remaining
							weighted-
					Weighted-		average		Per share
					average		contractual		average
				Price per	exercise		terms		intrinsic
	Options			share	price		(in years)		value
Outstanding as of December 31, 2019		980,884		$0.75-$83.30	$	35.24		2.84	$	34.07
Exercised		(9,324	)	1.17-44.19		20.00
Forfeited		(6,779	)	44.19-56.72		48.23
Outstanding as of September 30, 2020		964,781		0.75-83.30		35.30		2.09		5.56
Vested and exercisable as of September 30, 2020		964,781		0.75-83.30		35.30		2.09		5.56
Vested and expected to vest as of September 30, 2020		964,781		$0.75-$83.30	$	35.30		2.09	$	5.56

Summary of Restricted Stock Activity

Stock Awards activity for the nine months ended September 30, 2020 is summarized below:

										Weighted-
										average
										grant
				Performance						date fair
				and						value
Restricted stock units	Time-based			time-based			Total			per share
Unvested restricted stock units as of December 31, 2019		108,976			3,134			112,110		$	83.48
Granted		202,924			88,458			291,382			43.85
Vested		(42,040	)		—			(42,040	)		83.06
Forfeited/canceled		(18,858	)		(3,134	)		(21,992	)		76.90
Unvested restricted stock units as of September 30, 2020 ⁽¹⁾		251,002			88,458			339,460		$	50.52
Unvested and expected to vest restricted stock units outstanding as of September 30, 2020								251,623		$	51.24

										Weighted-
										average
										grant
				Performance						date fair
				and						value
Restricted stock awards	Time-based			time-based			Total			per share
Unvested restricted stock awards outstanding as of December 31, 2019		71,070			62,628			133,698		$	95.74
Vested		(22,704	)		—			(22,704	)		89.76
Forfeited/canceled		—			(29,273	)		(29,273	)		110.27
Unvested restricted stock awards outstanding as of September 30, 2020 ⁽¹⁾		48,366			33,355			81,721		$	93.42
Unvested and expected to vest restricted stock awards outstanding as of September 30, 2020								50,193		$	86.23

(1)	Outstanding restricted stock units and restricted stock awards are based on the maximum payout of the targeted number of shares.

Summary of Stock-based Compensation Expense

Stock-based compensation

Stock-based compensation expense recognized for the three and nine months ended September 30, 2020 and September 30, 2019, was as follows:

	Three months ended				Nine months ended
	September 30,				September 30,
	2020		2019		2020		2019
Stock-based compensation expense by type of award:
Stock option plan awards	$	—	$	590	$	709	$	2,513
Restricted stock units and restricted stock awards		1,878		834		4,853		3,882
Employee stock purchase plan		172		141		549		535
Total stock-based compensation expense	$	2,050	$	1,565	$	6,111	$	6,930

For the three and nine months ended September 30, 2020 and September 30, 2019, respectively, stock-based compensation expense recognized under ASC 718, included in cost of revenue, research and development expense, sales and marketing expense, and general and administrative expense was as follows:

	Three months ended				Nine months ended
	September 30,				September 30,
	2020		2019		2020		2019
Cost of revenue	$	185	$	172	$	511	$	656
Research and development		233		221		726		825
Sales and marketing		516		263		1,587		1,289
General and administrative		1,116		909		3,287		4,160
Total stock-based compensation expense	$	2,050	$	1,565	$	6,111	$	6,930